Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Rubius Therapeutics to Participate in Guggenheim Healthcare Talks | 2021 Oncology Days
Rubius TherapeuticsFebruary 3, 2021 GMT
CAMBRIDGE, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today announced that Pablo J. Cagnoni, M.D., president and chief executive officer, and the executive management team will participate in a fireside chat at the Guggenheim Healthcare Talks | 2021 Oncology Days on February 11, 2021, at 2:30 p.m. EST.